MedPath

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

Phase 3
Recruiting
Conditions
Asthma
Interventions
Registration Number
NCT06052267
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Brief Summary

The primary objective of the study is to assess the efficacy of high dose and low dose fluticasone propionate (Fp)/albuterol sulfate (ABS) integrated electronic module multidose dry powder inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).

Secondary Objectives:

To evaluate the efficacy of Fp/ABS compared to ABS and the effect on systemic corticosteroid (SCS) exposure

To evaluate the safety and tolerability of Fp/A BS

The duration for each participant will be a minimum of 28 weeks including 2 weeks of screening, 2-4 weeks of run-in period and a double blind treatment period of minimum 24 weeks, however due to the event-driven nature of this study, the duration may range up to approximately 35 months depending on the timing when the participant was enrolled to the study, and when the study reaches its completion criteria.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
2196
Inclusion Criteria
  • The participant has a documented diagnosis of asthma for at least 1 year according to the 2022 GINA guidelines.
  • The participant has a documented history of at least 1 severe clinical asthma exacerbation (CAE) ending within the past 12 month.
  • The participant is using any prescribed inhaled asthma controller medication (at a stable dose for 1 month prior to the screening visit).
  • If female, the participant is currently not pregnant, breastfeeding, or attempting to become pregnant (for at least 30 days before the screening visit and throughout the duration of the study), or is of nonchildbearing potential

NOTE- Additional criteria apply, please contact the investigator for more information.

Exclusion Criteria
  • The participant has life-threatening asthma defined as any history of significant asthma episode(s) requiring intubation associated with hypercapnia, respiratory arrest, hypoxic seizures, or asthma related syncopal episode(s) within 5 years before screening.
  • The participant has a suspected bacterial or viral infection (other than Coronavirus Disease [COVID-19]) of the upper or lower respiratory tract, sinus, or middle ear that has not resolved at least 2 weeks before the screening period.
  • Participants with a confirmed infection with COVID-19 within 6 weeks prior to the screening visit, or with residual COVID-19 symptoms ("long COVID-19").
  • The participant has had a clinical asthma exacerbation (CAE) requiring systemic corticosteroids within 30 days before screening, or any hospitalization for asthma within 2 months before screening.
  • The participant is a current smoker and/or has a history of ≥10 pack years history of smoking. A current smoker is defined as any participant who has used any form of tobacco product (including oral) within the past 6 months.
  • The participant has significantly abused alcohol and/or illicit prohibited drugs within the previous 24 months.
  • The participant has participated as a randomized participant in any investigational drug study within 30 days.
  • The participant has been hospitalized for psychiatric disorder or attempted suicide within 1 year of screening.

NOTE- Additional criteria apply, please contact the investigator for more information

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TEV-56248 Low DoseTEV-56248Inhalation powder via multidose dry powder inhaler with integrated electronic module (eMDPI) with a dosing frequency of 2 inhalations as needed to control asthma symptoms.
TEV-56248 High DoseTEV-56248Inhalation powder via multidose dry powder inhaler with integrated electronic module (eMDPI) with a dosing frequency of 2 inhalations as needed to control asthma symptoms.
Albuterol sulfateAlbuterol sulfateInhalation powder via multidose dry powder inhaler with integrated electronic module (eMDPI) with a dosing frequency of 2 inhalations as needed to control asthma symptoms.
Primary Outcome Measures
NameTimeMethod
Time to First Severe Clinical Asthma Exacerbation (CAE)Up to 35 months
Secondary Outcome Measures
NameTimeMethod
Number of Participants with at Least One Serious Adverse EventUp to 35 months
Number of Participants Who Withdrew From the Trial Due to Treatment-Emergent Adverse EventsUp to 35 months
Annualized Severe CAE RateUp to 35 months

Annualized severe CAE rate is calculated for each participant as the sum of total number of CAE events divided by the duration of follow up time (years).

Asthma Control Questionnaire-5 (ACQ-5) ResponseBaseline, Week 24

Response is defined as achieving a decrease in score from baseline value of at least 0.5 (participants aged ≥6 years).

The ACQ-5 is a shortened version of the validated asthma assessment tool (ie, ACQ) and includes 5 questions that are self-assessments (completed by the participant). Each item on the ACQ-5 has a possible score ranging from 0 to 6, and the total score is the mean of all responses.

Total Annualized SCS Exposure Over the Treatment PeriodUp to 35 months

Total annualized SCS exposure will be calculated for each participant as the sum of the cumulative doses of SCS divided by the duration of time (years) the participant was in the treatment period, from randomization and up to end of treatment.

Composite Responders Based on Asthma Quality of Life Questionnaire + 12 (AQLQ+12) or Pediatric AQLQ (PAQLQ)Baseline, Week 24

Responders are defined as the composite of participants achieving an increase in score from baseline of at least 0.5 on the AQLQ+12 or PAQLQ (participants aged ≥7 years).

The AQLQ + 12 is a modified version of the standardized AQLQ, which was developed to measure functional impairments experienced by adults ≥17 years of age. The AQLQ + 12 is valid for participants aged 12 to 70 years and includes 32 questions in 4 domains (symptoms, activity limitation, emotional function, and environmental stimuli). Responses are rated on a 7-point scale where 7 = no impairment and 1 = severe impairment.

The PAQLQ Questionnaire includes 23 items in 3 domains (symptoms, activity limitation, emotional function) and a 7-point scale (7 = not bothered at all; 1 = extremely bothered). It is intended for participants ages 7-11.

Number of Participants with at Least One Adverse EventUp to 35 months

Adverse events include clinically significant changes in clinical laboratory test results (serum chemistry, hematology, and urinalysis), vital signs measurements (blood pressure, pulse rate, body temperature, and respiratory rate), and 12-lead electrocardiogram (ECG) findings.

Trial Locations

Locations (370)

Teva Investigational Site 59222

🇧🇬

Plovdiv, Bulgaria

Teva Investigational Site 53524

🇵🇱

Gdansk, Poland

Teva Investigational Site 53538

🇵🇱

Gdansk, Poland

Teva Investigational Site 53530

🇵🇱

Krakow, Poland

Teva Investigational Site 53521

🇵🇱

Krakow, Poland

Teva Investigational Site 53528

🇵🇱

Lodz, Poland

Teva Investigational Site 53523

🇵🇱

Lublin, Poland

Teva Investigational Site 15768

🇺🇸

Dothan, Alabama, United States

Teva Investigational Site 15581

🇺🇸

Paradise Valley, Arizona, United States

Teva Investigational Site 15661

🇺🇸

Tucson, Arizona, United States

Teva Investigational Site 15685

🇺🇸

Bakersfield, California, United States

Teva Investigational Site 15721

🇺🇸

Fresno, California, United States

Teva Investigational Site 15788

🇺🇸

Huntington Beach, California, United States

Teva Investigational Site 15720

🇺🇸

La Jolla, California, United States

Teva Investigational Site 15687

🇺🇸

La Palma, California, United States

Teva Investigational Site 15708

🇺🇸

Long Beach, California, United States

Teva Investigational Site 15712

🇺🇸

Long Beach, California, United States

Teva Investigational Site 15643

🇺🇸

Los Angeles, California, United States

Teva Investigational Site 15695

🇺🇸

Napa, California, United States

Teva Investigational Site 15692

🇺🇸

Northridge, California, United States

Teva Investigational Site 15682

🇺🇸

Redondo Beach, California, United States

Teva Investigational Site 15629

🇺🇸

San Bernardino, California, United States

Teva Investigational Site 15709

🇺🇸

San Diego, California, United States

Teva Investigational Site 15704

🇺🇸

San Jose, California, United States

Teva Investigational Site 15620

🇺🇸

Stockton, California, United States

Teva Investigational Site 15621

🇺🇸

Westminster, California, United States

Teva Investigational Site 15612

🇺🇸

Aurora, Colorado, United States

Teva Investigational Site 15588

🇺🇸

Colorado Springs, Colorado, United States

Teva Investigational Site 15765

🇺🇸

Colorado Springs, Colorado, United States

Teva Investigational Site 15676

🇺🇸

Englewood, Colorado, United States

Teva Investigational Site 15781

🇺🇸

Washington, District of Columbia, United States

Teva Investigational Site 15660

🇺🇸

Aventura, Florida, United States

Teva Investigational Site 15624

🇺🇸

Cape Coral, Florida, United States

Teva Investigational Site 15598

🇺🇸

Cutler Bay, Florida, United States

Teva Investigational Site 15776

🇺🇸

Doral, Florida, United States

Teva Investigational Site 15579

🇺🇸

Greenacres City, Florida, United States

Teva Investigational Site 15582

🇺🇸

Hialeah, Florida, United States

Teva Investigational Site 15664

🇺🇸

Hialeah, Florida, United States

Teva Investigational Site 15657

🇺🇸

Homestead, Florida, United States

Teva Investigational Site 15713

🇺🇸

Jacksonville, Florida, United States

Teva Investigational Site 15632

🇺🇸

Leesburg, Florida, United States

Teva Investigational Site 15777

🇺🇸

Margate, Florida, United States

Teva Investigational Site 15589

🇺🇸

Miami Lakes, Florida, United States

Teva Investigational Site 15599

🇺🇸

Miami Lakes, Florida, United States

Teva Investigational Site 15595

🇺🇸

Miami Lakes, Florida, United States

Teva Investigational Site 15602

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15722

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15724

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15655

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15605

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15634

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15596

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15654

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15773

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15652

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15585

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15639

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15645

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15772

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15592

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15769

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15644

🇺🇸

Miami, Florida, United States

Teva Investigational Site 15665

🇺🇸

Oldsmar, Florida, United States

Teva Investigational Site 15659

🇺🇸

Orlando, Florida, United States

Teva Investigational Site 15617

🇺🇸

Orlando, Florida, United States

Teva Investigational Site 15625

🇺🇸

Orlando, Florida, United States

Teva Investigational Site 15597

🇺🇸

Pembroke Pines, Florida, United States

Teva Investigational Site 15767

🇺🇸

Sweetwater, Florida, United States

Teva Investigational Site 15587

🇺🇸

Tamarac, Florida, United States

Teva Investigational Site 15611

🇺🇸

Tampa, Florida, United States

Teva Investigational Site 15619

🇺🇸

Tampa, Florida, United States

Teva Investigational Site 15653

🇺🇸

Tampa, Florida, United States

Teva Investigational Site 15606

🇺🇸

Winter Park, Florida, United States

Teva Investigational Site 15711

🇺🇸

College Park, Georgia, United States

Teva Investigational Site 15626

🇺🇸

Savannah, Georgia, United States

Teva Investigational Site 15604

🇺🇸

Boise, Idaho, United States

Teva Investigational Site 15669

🇺🇸

Chicago, Illinois, United States

Teva Investigational Site 15600

🇺🇸

Skokie, Illinois, United States

Teva Investigational Site 15674

🇺🇸

Evansville, Indiana, United States

Teva Investigational Site 15580

🇺🇸

Overland Park, Kansas, United States

Teva Investigational Site 15627

🇺🇸

Lexington, Kentucky, United States

Teva Investigational Site 15770

🇺🇸

Lafayette, Louisiana, United States

Teva Investigational Site 15667

🇺🇸

Bangor, Maine, United States

Teva Investigational Site 15689

🇺🇸

Rockville, Maryland, United States

Teva Investigational Site 15583

🇺🇸

White Marsh, Maryland, United States

Teva Investigational Site 15628

🇺🇸

Boston, Massachusetts, United States

Teva Investigational Site 15686

🇺🇸

Fall River, Massachusetts, United States

Teva Investigational Site 15663

🇺🇸

North Dartmouth, Massachusetts, United States

Teva Investigational Site 15764

🇺🇸

South Dartmouth, Massachusetts, United States

Teva Investigational Site 15702

🇺🇸

Detroit, Michigan, United States

Teva Investigational Site 15701

🇺🇸

Flint, Michigan, United States

Teva Investigational Site 15593

🇺🇸

Ypsilanti, Michigan, United States

Teva Investigational Site 15648

🇺🇸

Kansas City, Missouri, United States

Teva Investigational Site 15640

🇺🇸

Saint Louis, Missouri, United States

Teva Investigational Site 15650

🇺🇸

Saint Louis, Missouri, United States

Teva Investigational Site 15633

🇺🇸

Saint Louis, Missouri, United States

Teva Investigational Site 15679

🇺🇸

Las Vegas, Nevada, United States

Teva Investigational Site 15725

🇺🇸

North Bergen, New Jersey, United States

Teva Investigational Site 15688

🇺🇸

Hawthorne, New York, United States

Teva Investigational Site 15603

🇺🇸

Horseheads, New York, United States

Teva Investigational Site 15666

🇺🇸

Hyde Park, New York, United States

Teva Investigational Site 15675

🇺🇸

New Windsor, New York, United States

Teva Investigational Site 15618

🇺🇸

Asheville, North Carolina, United States

Teva Investigational Site 15601

🇺🇸

Chapel Hill, North Carolina, United States

Teva Investigational Site 15697

🇺🇸

Charlotte, North Carolina, United States

Teva Investigational Site 15610

🇺🇸

Elizabeth City, North Carolina, United States

Teva Investigational Site 15651

🇺🇸

High Point, North Carolina, United States

Teva Investigational Site 15771

🇺🇸

Statesville, North Carolina, United States

Teva Investigational Site 15631

🇺🇸

Wilmington, North Carolina, United States

Teva Investigational Site 15584

🇺🇸

Winston-Salem, North Carolina, United States

Teva Investigational Site 15607

🇺🇸

Cincinnati, Ohio, United States

Teva Investigational Site 15613

🇺🇸

Columbus, Ohio, United States

Teva Investigational Site 15784

🇺🇸

Dayton, Ohio, United States

Teva Investigational Site 15780

🇺🇸

Toledo, Ohio, United States

Teva Investigational Site 15662

🇺🇸

Toledo, Ohio, United States

Teva Investigational Site 15577

🇺🇸

Oklahoma City, Oklahoma, United States

Teva Investigational Site 15594

🇺🇸

Tulsa, Oklahoma, United States

Teva Investigational Site 15775

🇺🇸

Yukon, Oklahoma, United States

Teva Investigational Site 15646

🇺🇸

Grants Pass, Oregon, United States

Teva Investigational Site 15642

🇺🇸

Philadelphia, Pennsylvania, United States

Teva Investigational Site 15699

🇺🇸

Philadelphia, Pennsylvania, United States

Teva Investigational Site 15576

🇺🇸

Pittsburgh, Pennsylvania, United States

Teva Investigational Site 20138

🇦🇷

Caba, Argentina

Teva Investigational Site 15608

🇺🇸

North Charleston, South Carolina, United States

Teva Investigational Site 15672

🇺🇸

Rock Hill, South Carolina, United States

Teva Investigational Site 15691

🇺🇸

Knoxville, Tennessee, United States

Teva Investigational Site 15705

🇺🇸

Austin, Texas, United States

Teva Investigational Site 15641

🇺🇸

Boerne, Texas, United States

Teva Investigational Site 15778

🇺🇸

Brownsville, Texas, United States

Teva Investigational Site 15668

🇺🇸

Corsicana, Texas, United States

Teva Investigational Site 15658

🇺🇸

Dallas, Texas, United States

Teva Investigational Site 15637

🇺🇸

Dallas, Texas, United States

Teva Investigational Site 15623

🇺🇸

Dallas, Texas, United States

Teva Investigational Site 15785

🇺🇸

Edinburg, Texas, United States

Teva Investigational Site 15678

🇺🇸

El Paso, Texas, United States

Teva Investigational Site 15787

🇺🇸

El Paso, Texas, United States

Teva Investigational Site 15591

🇺🇸

El Paso, Texas, United States

Teva Investigational Site 15696

🇺🇸

Houston, Texas, United States

Teva Investigational Site 15680

🇺🇸

Houston, Texas, United States

Teva Investigational Site 15614

🇺🇸

Houston, Texas, United States

Teva Investigational Site 15578

🇺🇸

Houston, Texas, United States

Teva Investigational Site 15690

🇺🇸

Katy, Texas, United States

Teva Investigational Site 15684

🇺🇸

Kerrville, Texas, United States

Teva Investigational Site 15630

🇺🇸

McKinney, Texas, United States

Teva Investigational Site 15706

🇺🇸

Plano, Texas, United States

Teva Investigational Site 15656

🇺🇸

San Antonio, Texas, United States

Teva Investigational Site 15670

🇺🇸

San Antonio, Texas, United States

Teva Investigational Site 15638

🇺🇸

San Antonio, Texas, United States

Teva Investigational Site 15647

🇺🇸

Sherman, Texas, United States

Teva Investigational Site 15673

🇺🇸

Splendora, Texas, United States

Teva Investigational Site 15707

🇺🇸

Tomball, Texas, United States

Teva Investigational Site 15693

🇺🇸

Victoria, Texas, United States

Teva Investigational Site 15649

🇺🇸

Waxahachie, Texas, United States

Teva Investigational Site 15671

🇺🇸

Bountiful, Utah, United States

Teva Investigational Site 15635

🇺🇸

Sandy, Utah, United States

Teva Investigational Site 15789

🇺🇸

West Valley City, Utah, United States

Teva Investigational Site 15683

🇺🇸

Williamsburg, Virginia, United States

Teva Investigational Site 15586

🇺🇸

Greenfield, Wisconsin, United States

Teva Investigational Site 20109

🇦🇷

Bahia Blanca, Argentina

Teva Investigational Site 20126

🇦🇷

Bahia Blanca, Argentina

Teva Investigational Site 20130

🇦🇷

Bahia Blanca, Argentina

Teva Investigational Site 20117

🇦🇷

Buenos Aires Province, Argentina

Teva Investigational Site 20113

🇦🇷

Buenos Aires, Argentina

Teva Investigational Site 20111

🇦🇷

Buenos Aires, Argentina

Teva Investigational Site 20129

🇦🇷

CapitalFederal, Argentina

Teva Investigational Site 20135

🇦🇷

Caba, Argentina

Teva Investigational Site 20128

🇦🇷

Caba, Argentina

Teva Investigational Site 20139

🇦🇷

Caba, Argentina

Teva Investigational Site 20121

🇦🇷

Ciudad de Mendoza, Argentina

Teva Investigational Site 20118

🇦🇷

Concepcion del Uruguay, Argentina

Teva Investigational Site 20106

🇦🇷

Cordoba Capital, Argentina

Teva Investigational Site 20114

🇦🇷

Florencio Varela, Argentina

Teva Investigational Site 20125

🇦🇷

Florida, Vicente Lopez, Argentina

Teva Investigational Site 20136

🇦🇷

Godoy Cruz, Argentina

Teva Investigational Site 20122

🇦🇷

Lanus Este, Argentina

Teva Investigational Site 20107

🇦🇷

Lobos, Argentina

Teva Investigational Site 20123

🇦🇷

Mar Del Plata, Argentina

Teva Investigational Site 20127

🇦🇷

Mendoza, Argentina

Teva Investigational Site 20110

🇦🇷

Mendoza, Argentina

Teva Investigational Site 20115

🇦🇷

Mendoza, Argentina

Teva Investigational Site 20140

🇦🇷

Parana, Argentina

Teva Investigational Site 20112

🇦🇷

Quilmes, Argentina

Teva Investigational Site 20119

🇦🇷

Rosario, Argentina

Teva Investigational Site 20120

🇦🇷

Rosario, Argentina

Teva Investigational Site 20105

🇦🇷

Rosario, Argentina

Teva Investigational Site 20133

🇦🇷

San Fernando, Argentina

Teva Investigational Site 20104

🇦🇷

San Miguel de Tucuman, Argentina

Teva Investigational Site 20124

🇦🇷

San Miguel De Tucuman, Argentina

Teva Investigational Site 20131

🇦🇷

San Miguel de Tucuman, Argentina

Teva Investigational Site 20137

🇦🇷

San Miguel de Tucuman, Argentina

Teva Investigational Site 78127

🇦🇺

South Brisbane, Australia

Teva Investigational Site 20116

🇦🇷

San Rafael, Argentina

Teva Investigational Site 20132

🇦🇷

Santa Fe, Argentina

Teva Investigational Site 78131

🇦🇺

Box Hill, Australia

Teva Investigational Site 78133

🇦🇺

Melbourne, Australia

Teva Investigational Site 78132

🇦🇺

Midland, Australia

Teva Investigational Site 78130

🇦🇺

Nedlands, Australia

Teva Investigational Site 78134

🇦🇺

North Adelaide, Australia

Teva Investigational Site 78128

🇦🇺

Parkville, Australia

Teva Investigational Site 59230

🇧🇬

Blagoevgrad, Bulgaria

Teva Investigational Site 59227

🇧🇬

Kozloduy, Bulgaria

Teva Investigational Site 59218

🇧🇬

Pernik, Bulgaria

Teva Investigational Site 59237

🇧🇬

Pleven, Bulgaria

Teva Investigational Site 59219

🇧🇬

Ruse, Bulgaria

Teva Investigational Site 59231

🇧🇬

Sliven, Bulgaria

Teva Investigational Site 59224

🇧🇬

Sofia, Bulgaria

Teva Investigational Site 59226

🇧🇬

Sofia, Bulgaria

Teva Investigational Site 59235

🇧🇬

Sofia, Bulgaria

Teva Investigational Site 59228

🇧🇬

Sofia, Bulgaria

Teva Investigational Site 59234

🇧🇬

Sofia, Bulgaria

Teva Investigational Site 59221

🇧🇬

Sofia, Bulgaria

Teva Investigational Site 59220

🇧🇬

Stara Zagora, Bulgaria

Teva Investigational Site 59232

🇧🇬

Varna, Bulgaria

Teva Investigational Site 59229

🇧🇬

Vratsa, Bulgaria

Teva Investigational Site 11267

🇨🇦

Edmonton, Alberta, Canada

Teva Investigational Site 11272

🇨🇦

Ajax, Ontario, Canada

Teva Investigational Site 11270

🇨🇦

Etobicoke, Ontario, Canada

Teva Investigational Site 11274

🇨🇦

Hamilton, Ontario, Canada

Teva Investigational Site 11271

🇨🇦

Winchester, Ontario, Canada

Teva Investigational Site 11273

🇨🇦

Windsor, Ontario, Canada

Teva Investigational Site 54231

🇨🇿

Brandys Nad Labem-stara Boleslav, Czechia

Teva Investigational Site 54232

🇨🇿

Brno, Czechia

Teva Investigational Site 54229

🇨🇿

Jihlava, Czechia

Teva Investigational Site 54226

🇨🇿

Jindrichuv Hradec, Czechia

Teva Investigational Site 54225

🇨🇿

Lovosice, Czechia

Teva Investigational Site 54228

🇨🇿

Ostrava, Czechia

Teva Investigational Site 32848

🇩🇪

Hamburg, Germany

Teva Investigational Site 54230

🇨🇿

Prague, Czechia

Teva Investigational Site 54227

🇨🇿

Varnsdorf, Czechia

Teva Investigational Site 39099

🇩🇰

Aalborg, Denmark

Teva Investigational Site 39100

🇩🇰

Hvidovre, Denmark

Teva Investigational Site 39098

🇩🇰

Vejle, Denmark

Teva Investigational Site 32846

🇩🇪

Augsburg, Germany

Teva Investigational Site 32835

🇩🇪

Berlin, Germany

Teva Investigational Site 32834

🇩🇪

Berlin, Germany

Teva Investigational Site 32833

🇩🇪

Berlin, Germany

Teva Investigational Site 32840

🇩🇪

Cottbus, Germany

Teva Investigational Site 32829

🇩🇪

Darmstadt, Germany

Teva Investigational Site 32850

🇩🇪

Delitzsch, Germany

Teva Investigational Site 32853

🇩🇪

Essen, Germany

Teva Investigational Site 32845

🇩🇪

Frankfurt Am Main, Germany

Teva Investigational Site 32831

🇩🇪

Frankfurt, Germany

Teva Investigational Site 32838

🇩🇪

Hamburg, Germany

Teva Investigational Site 32827

🇩🇪

Hamburg, Germany

Teva Investigational Site 32841

🇩🇪

Hannover, Germany

Teva Investigational Site 32842

🇩🇪

Heidelberg, Germany

Teva Investigational Site 32851

🇩🇪

Ibbenbueren, Germany

Teva Investigational Site 32830

🇩🇪

Leipzig - Nordost, Germany

Teva Investigational Site 32844

🇩🇪

Leipzig, Germany

Teva Investigational Site 32832

🇩🇪

Mainz A. Rhein, Germany

Teva Investigational Site 32847

🇩🇪

Munchen, Germany

Teva Investigational Site 32828

🇩🇪

Munchen, Germany

Teva Investigational Site 32843

🇩🇪

Neu-Isenburg, Germany

Teva Investigational Site 32839

🇩🇪

Neuss, Germany

Teva Investigational Site 32836

🇩🇪

Peine, Germany

Teva Investigational Site 32849

🇩🇪

Wiesbaden, Germany

Teva Investigational Site 32852

🇩🇪

Witten, Germany

Teva Investigational Site 63086

🇬🇷

Athens, Greece

Teva Investigational Site 63085

🇬🇷

Evros, Greece

Teva Investigational Site 63087

🇬🇷

Larissa, Greece

Teva Investigational Site 63082

🇬🇷

Thessaloniki, Greece

Teva Investigational Site 63083

🇬🇷

Thessaloniki, Greece

Teva Investigational Site 51346

🇭🇺

Budapest, Hungary

Teva Investigational Site 51344

🇭🇺

Budapest, Hungary

Teva Investigational Site 51340

🇭🇺

Budapest, Hungary

Teva Investigational Site 51342

🇭🇺

Debrecen, Hungary

Teva Investigational Site 51345

🇭🇺

Mosonmagyarovar, Hungary

Teva Investigational Site 51343

🇭🇺

Pecs, Hungary

Teva Investigational Site 51339

🇭🇺

Szeged, Hungary

Teva Investigational Site 51341

🇭🇺

Szigetvar, Hungary

Teva Investigational Site 80196

🇮🇱

Ashkelon, Israel

Teva Investigational Site 80201

🇮🇱

Beer Sheva, Israel

Teva Investigational Site 80200

🇮🇱

Haifa, Israel

Teva Investigational Site 80194

🇮🇱

Jerusalem, Israel

Teva Investigational Site 80198

🇮🇱

Jerusalem, Israel

Teva Investigational Site 80199

🇮🇱

Petach Tikvah, Israel

Teva Investigational Site 80195

🇮🇱

Petah Tikva, Israel

Teva Investigational Site 80193

🇮🇱

Rehovot, Israel

Teva Investigational Site 80197

🇮🇱

Tel Aviv-Yafo, Israel

Teva Investigational Site 30306

🇮🇹

Ferrara, Italy

Teva Investigational Site 30317

🇮🇹

Pisa, Italy

Teva Investigational Site 30307

🇮🇹

Verona, Italy

Teva Investigational Site 87039

🇰🇷

Seoul, Korea, Republic of

Teva Investigational Site 87044

🇰🇷

Seoul, Korea, Republic of

Teva Investigational Site 87043

🇰🇷

Seoul, Korea, Republic of

Teva Investigational Site 87042

🇰🇷

Seoul, Korea, Republic of

Teva Investigational Site 87040

🇰🇷

Seoul, Korea, Republic of

Teva Investigational Site 87041

🇰🇷

Seoul, Korea, Republic of

Teva Investigational Site 56016

🇱🇻

Balvi, Latvia

Teva Investigational Site 56019

🇱🇻

Daugavpils, Latvia

Teva Investigational Site 56017

🇱🇻

Jurmala, Latvia

Teva Investigational Site 56015

🇱🇻

Rezekne, Latvia

Teva Investigational Site 56014

🇱🇻

Riga, Latvia

Teva Investigational Site 56013

🇱🇻

Riga, Latvia

Teva Investigational Site 56020

🇱🇻

Riga, Latvia

Teva Investigational Site 53537

🇵🇱

Elblag, Poland

Teva Investigational Site 56018

🇱🇻

Riga, Latvia

Teva Investigational Site 79054

🇳🇿

Auckland, New Zealand

Teva Investigational Site 79056

🇳🇿

Auckland, New Zealand

Teva Investigational Site 79055

🇳🇿

Christchurch, New Zealand

Teva Investigational Site 79057

🇳🇿

Dunedin, New Zealand

Teva Investigational Site 79051

🇳🇿

Hamilton, New Zealand

Teva Investigational Site 79062

🇳🇿

Nawton, New Zealand

Teva Investigational Site 79061

🇳🇿

Nelson, New Zealand

Teva Investigational Site 79059

🇳🇿

Rotorua, New Zealand

Teva Investigational Site 79060

🇳🇿

South Hastings, New Zealand

Teva Investigational Site 79052

🇳🇿

Tauranga, New Zealand

Teva Investigational Site 79058

🇳🇿

Waikanae Beach, New Zealand

Teva Investigational Site 79050

🇳🇿

Wellington, New Zealand

Teva Investigational Site 53531

🇵🇱

Bialystok, Poland

Teva Investigational Site 53527

🇵🇱

Bialystok, Poland

Teva Investigational Site 53534

🇵🇱

Bydgoszcz, Poland

Teva Investigational Site 53522

🇵🇱

Makow Podhalanski, Poland

Teva Investigational Site 53525

🇵🇱

Ostrowiec Swietokrzyski, Poland

Teva Investigational Site 53532

🇵🇱

Poznan, Poland

Teva Investigational Site 53526

🇵🇱

Rzeszow, Poland

Teva Investigational Site 53536

🇵🇱

Skierniewice, Poland

Teva Investigational Site 53535

🇵🇱

Warszawa, Poland

Teva Investigational Site 53529

🇵🇱

Zawadzkie, Poland

Teva Investigational Site 52139

🇷🇴

Bacau, Romania

Teva Investigational Site 52140

🇷🇴

Bragadiru, Romania

Teva Investigational Site 52138

🇷🇴

Bucuresti, Romania

Teva Investigational Site 52136

🇷🇴

Bucuresti, Romania

Teva Investigational Site 52135

🇷🇴

Cluj Napoca, Romania

Teva Investigational Site 52137

🇷🇴

Craiova, Romania

Teva Investigational Site 61071

🇷🇸

Belgrade, Serbia

Teva Investigational Site 61075

🇷🇸

Belgrade, Serbia

Teva Investigational Site 61076

🇷🇸

Belgrade, Serbia

Teva Investigational Site 61073

🇷🇸

Beograd, Serbia

Teva Investigational Site 61074

🇷🇸

Beograd, Serbia

Teva Investigational Site 61080

🇷🇸

Beograd, Serbia

Teva Investigational Site 61077

🇷🇸

Beograd, Serbia

Teva Investigational Site 61078

🇷🇸

Kragujevac, Serbia

Teva Investigational Site 61070

🇷🇸

Nis, Serbia

Teva Investigational Site 61079

🇷🇸

Novi Sad, Serbia

Teva Investigational Site 61072

🇷🇸

Sremska Kamenica, Serbia

Teva Investigational Site 62083

🇸🇰

Bardejov, Slovakia

Teva Investigational Site 62082

🇸🇰

Kosice, Slovakia

Teva Investigational Site 62080

🇸🇰

Rimavska Sobota, Slovakia

Teva Investigational Site 62077

🇸🇰

Slovakia, Slovakia

Teva Investigational Site 62078

🇸🇰

Spisska Nova Ves, Slovakia

Teva Investigational Site 62079

🇸🇰

Zilina, Slovakia

Teva Investigational Site 62081

🇸🇰

Zilina, Slovakia

Teva Investigational Site 90078

🇿🇦

Benoni, South Africa

Teva Investigational Site 90069

🇿🇦

Cape Town, South Africa

Teva Investigational Site 90077

🇿🇦

Cape Town, South Africa

Teva Investigational Site 90063

🇿🇦

Cape town, South Africa

Teva Investigational Site 90079

🇿🇦

Cape Town, South Africa

Teva Investigational Site 90073

🇿🇦

Chatsworth, South Africa

Teva Investigational Site 90067

🇿🇦

Durban, South Africa

Teva Investigational Site 90070

🇿🇦

Ennerdale, South Africa

Teva Investigational Site 90083

🇿🇦

Germiston, South Africa

Teva Investigational Site 90062

🇿🇦

Johannesburg, South Africa

Teva Investigational Site 90074

🇿🇦

Krugersdorp, South Africa

Teva Investigational Site 90064

🇿🇦

Middelburg, South Africa

Teva Investigational Site 90072

🇿🇦

Midrand, South Africa

Teva Investigational Site 90071

🇿🇦

Plettenberg Bay, South Africa

Teva Investigational Site 90081

🇿🇦

Polokwane, South Africa

Teva Investigational Site 90076

🇿🇦

Pretoria, South Africa

Teva Investigational Site 90080

🇿🇦

Raslouw, South Africa

Teva Investigational Site 90068

🇿🇦

Roodepoort, South Africa

Teva Investigational Site 90066

🇿🇦

Somerset West, South Africa

Teva Investigational Site 90065

🇿🇦

Stanger, South Africa

Teva Investigational Site 31305

🇪🇸

Barcelona, Spain

Teva Investigational Site 31307

🇪🇸

Barcelona, Spain

Teva Investigational Site 31309

🇪🇸

Cordoba, Spain

Teva Investigational Site 31303

🇪🇸

Madrid, Spain

Teva Investigational Site 31306

🇪🇸

Santiago de Compostela, Spain

Teva Investigational Site 31311

🇪🇸

Sevilla, Spain

Teva Investigational Site 31308

🇪🇸

Valencia, Spain

© Copyright 2025. All Rights Reserved by MedPath